< Back to all Breaking News
ARTH
3/14/2018 08:03am
Arch Therapeutics downgraded to Outperform from Strong Buy at IFS Securities 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
